Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Lindsay Kipnis"'
Autor:
Whitney Espinel, Marjan Champine, Heather Hampel, Joanne Jeter, Kevin Sweet, Robert Pilarski, Rachel Pearlman, Kate Shane, Pamela Brock, Judith A. Westman, Lindsay Kipnis, Jilliane Sotelo, Anu Chittenden, Samantha Culver, Jill E. Stopfer, Katherine A. Schneider, Rosalba Sacca, Diane R. Koeller, Shraddha Gaonkar, Erica Vaccari, Sarah Kane, Scott T. Michalski, Shan Yang, Sarah M. Nielsen, Sara L. Bristow, Stephen E. Lincoln, Robert L. Nussbaum, Edward D. Esplin
Publikováno v:
Cancers, Vol 14, Iss 10, p 2426 (2022)
Consensus guidelines for hereditary breast and ovarian cancer include management recommendations for pathogenic/likely pathogenic (P/LP) variants in ATM, CHEK2, PALB2, and other DNA damage repair (DDR) genes beyond BRCA1 or BRCA2. We report on clinic
Externí odkaz:
https://doaj.org/article/66f94b1a0c9f4285aa1e9cb13473dfd6
Autor:
Rebecca A. Vanderwall, Alison Schwartz, Lindsay Kipnis, Catherine M. Skefos, Samantha M. Stokes, Nizar Bhulani, Michelle Weitz, Rebecca Gelman, Judy E. Garber, Huma Q. Rana
Publikováno v:
Journal of the National Comprehensive Cancer Network : JNCCN. 20(8)
Background: Cancer family history is a vital part of cancer genetic counseling (GC) and genetic testing (GT), but increasing indications for germline cancer GT necessitate less labor-intensive models of collection. We evaluated the impact of GC on pa
Autor:
Steven M. Blum, William R. Jeck, Lindsay Kipnis, Ronald Bleday, Jonathan A. Nowak, Matthew B. Yurgelun
Publikováno v:
Journal of the National Comprehensive Cancer Network : JNCCN. 19(12)
Two major molecular pathways of colorectal carcinogenesis, chromosomal instability (CIN) and microsatellite instability (MSI), are considered to be mutually exclusive. Distinguishing CIN from MSI-high tumors has considerable therapeutic implications,
Autor:
Fatemeh Fekrmandi, Tim Jaung, Alexi A. Wright, Judy Garber, Huma Q. Rana, Kristin Hehir, Ursula A. Matulonis, Angel M. Cronin, Samantha Stokes, Lindsay Kipnis, Donna Rachel Vatnick
Publikováno v:
Gynecologic oncology. 160(2)
Objective Germline genetic testing is crucial to the care of ovarian cancer patients, and as part of the guideline-based care for ovarian cancer patient's adherence to this recommendation has been low. We sought to determine whether embedding a genet
Autor:
Jill E. Stopfer, Lindsay Kipnis, Sara Pirzadeh-Miller, ProGen Study Team, Kevin D. Courtney, Samantha Culver, Diane R. Koeller, Jill S. Dolinsky, Donna Rachel Vatnick, Virginia Speare, Mary-Ellen Taplin, Judy Garber, Theodora S. Ross, Nancie Petrucelli, Huma Q. Rana, Rebecca Silver, Elisabeth I. Heath, Rebecca Gelman, Michelle Weitz, Brian Reys, Joanna Mercado
Publikováno v:
Journal of Clinical Oncology. 38:1507-1507
1507 Background: Approximately 10% of men with advanced prostate cancer (PC) have pathogenic/likely pathogenic variants (PV) in cancer susceptibility genes and their identification may lead to targeted therapy. Genetic testing (GT) can also guide can
Autor:
Samantha Culver, Christopher Sweeney, Jill E. Stopfer, Virginia Speare, Mark Pomerantz, Alexander E. Husband, Huma Q. Rana, Lindsay Kipnis, Sandjida Aktar, Judy Garber, Donna Rachel Vatnick, Kerry L. Kilbridge, Brigette Tippin Davis, Diane R. Koeller, Bradley Alexander McGregor, Kyle Allen, Jill S. Dolinsky, Mary-Ellen Taplin
Publikováno v:
Journal of Clinical Oncology. 37:TPS343-TPS343
TPS343 Background: Prostate cancer (PC) is among the leading causes of cancer mortality in males. Recent studies found 8-12% of advanced PC cases may be hereditary. Germline mutations have been reported in BRCA1/2, other DNA repair genes including AT
Autor:
Rachel Pearlman, Heather Hampel, Rosalba Sacca, Robert Pilarski, Katherine A. Schneider, Pamela Brock, Edward D. Esplin, Whitney Espinel, Diane R. Koeller, Kevin Sweet, Lindsay Kipnis, Anu Chittenden, Joanne M. Jeter, Marjan Champine, Jill Stopfer, Shraddha Gaonkar, Jilliane Sotelo, Kate P Shane-Carson, Judith A. Westman, Samantha Stickevers
Publikováno v:
Journal of Clinical Oncology. 36:e18705-e18705
e18705Background: Germline testing guidelines are centered on BRCA1 and BRCA2 despite clear medical management recommendations in several other high and moderate penetrance genes. Clinician utiliza...